September 26, 2007 - GlucoLight Corporation, a development-stage company focused on blood glucose monitoring in the acute care environment, announced that it has been awarded U.S. Patent No. 7,254,429 for the technology that is the core of the company’s first product, the Sentris-100™ glucose monitor... Sentris-100 is currently in clinical testing and the Company recently completed its first hypoglycemic “clamping study” that measured blood glucose fluctuations in volunteer subjects with Type 1 diabetes..... GlucoLight's Press Release -
Friday, September 28, 2007
GlucoLight, Patent for Sentris-100™ Blood Glucose Monitoring Technology
September 26, 2007 - GlucoLight Corporation, a development-stage company focused on blood glucose monitoring in the acute care environment, announced that it has been awarded U.S. Patent No. 7,254,429 for the technology that is the core of the company’s first product, the Sentris-100™ glucose monitor... Sentris-100 is currently in clinical testing and the Company recently completed its first hypoglycemic “clamping study” that measured blood glucose fluctuations in volunteer subjects with Type 1 diabetes..... GlucoLight's Press Release -
